ASIA PACIFIC DRUG DISCOVERY MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC DRUG DISCOVERY MARKET FORECAST 2019-2027

ASIA PACIFIC DRUG DISCOVERY MARKET FORECAST 2019-2027

The Asia Pacific drug discovery market is expected to rise with the CAGR of 8.97% over the forecast period of 2019-2027. By the end of 2027, the Asia Pacific market is expected to account for a revenue share of $XX million and capture XX% share in the global drug discovery market. Asian Pacific region showcases promising market as various global healthcare companies have been planning to set up their business in these countries. Several global market players are vying to capture this untapped region as extensive research & development for new product launches is gaining momentum in the Asia Pacific.

ASIA PACIFIC DRUG DISCOVERY MARKET FORECAST 2019-2027

Asia Pacific Drug Discovery Market by Technology (High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics and Pharmacogenetics, Combinatorial, Chemistry, Nanotechnology, Spectroscopy, Metabolomics, Other Technologies) by Drug Type (Small Molecule Drug, Biologic Drug) by Service (Drug Metabolism and Pharmacokinetics, (Dmpk) Services, Chemical Services, Biological Services, Other Pharmaceutical Services) by End User (Research Institutes, Pharmaceutical Companies, Contract Research Organizations (Cros), Other End User) by Geography.

Request free sample

Report Summary

The Asia Pacific drug discovery market is expected to rise with the CAGR of 8.97% over the forecast period of 2019-2027. By the end of 2027, the Asia Pacific market is expected to account for a revenue share of $XX million and capture XX% share in the global drug discovery market.

Asian Pacific region showcases promising market as various global healthcare companies have been planning to set up their business in these countries. Several global market players are vying to capture this untapped region as extensive research & development for new product launches is gaining momentum in the Asia Pacific. Also, the healthcare system in the region is improving and adopting the latest technology for surgeries and treatments. As a result of this, drug discovery showcases the huge market potential in the region.

The Asia Pacific drug discovery market comprises of several countries, namely Japan, India, South Korea, Australia, China, and Rest of Asia Pacific region that is formed by other APAC countries. The China drug discovery market is growing as many Chinese companies are providing contract research services for drug discovery and development. They have shown significant progress and considerably established themselves in recent years. Also, several private, as well as public sectors in China, are investing a considerable amount to support drug discovery and development, thereby fueling its market growth in the region.

Many multinational pharmaceutical giants are outsourcing their R&D to emerging economies like India and China. For instance, pharmaceutical company Eli Lily outsourced research & development to China. Some of the other companies operating in the drug discovery market are Bayer AG, Antares Pharma, Becton, Dickinson & Company (BD), 3M Company, and AstraZeneca PLC.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Table of Contents

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • HIGH PREVALENCE RATES OF MAJOR HEALTH DISORDERS
      • IMPLEMENTATION OF DRUG DISCOVERY PROGRAMS
      • BIOINFORMATICS IS THE WIDELY USED DRUG DISCOVERY TECHNOLOGY
      • SMALL MOLECULE DRUG TYPE CONSTITUTES THE HIGHEST MARKET SHARE
      • CONTRACT RESEARCH ORGANIZATIONS (CROS) ARE THE FASTEST GROWING END USER
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • AGING POPULATION
      • BRANDED DRUGS ARE OUTPERFORMING DUE TO HIGH COST COMPARED TO GENERIC DRUGS
      • GROWING HEALTHCARE EXPENDITURE
      • TECHNOLOGICAL ADVANCEMENT
    • MARKET RESTRAINTS
      • DELAY IN PRODUCT LAUNCHES
      • POOR ACCESS TO HEALTHCARE SERVICES IN DEVELOPING MARKETS
      • SHIFT FROM BRANDED TO GENERIC DRUGS
    • MARKET OPPORTUNITIES
      • EXTENSIVE R & D FOR NEW PRODUCT LAUNCHES
      • INCREASING DEMAND FOR SPECIALTY MEDICINES
      • RISING INVESTMENT BY PHARMACEUTICAL COMPANIES IN IMPROVING BIG-DATA ANALYTICAL CAPABILITIES
    • MARKET CHALLENGES
      • COST BARRIER FOR LOCAL PEOPLE IN EMERGING ECONOMIES
      • STRINGENT GOVERNMENT REGULATIONS
  1. MARKET BY TECHNOLOGY
    • HIGH THROUGHPUT SCREENING
    • BIOCHIPS
    • BIOINFORMATICS
    • PHARMACOGENOMICS AND PHARMACOGENETICS
    • COMBINATORIAL CHEMISTRY
    • NANOTECHNOLOGY
    • SPECTROSCOPY
    • METABOLOMICS
    • OTHER TECHNOLOGIES
  2. MARKET BY DRUG TYPE
    • SMALL MOLECULE DRUG
    • BIOLOGIC DRUG
  3. MARKET BY SERVICE
    • DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
    • CHEMICAL SERVICES
    • BIOLOGICAL SERVICES
    • OTHER PHARMACEUTICAL SERVICES
  4. MARKET BY END USER
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL COMPANIES
    • CONTRACT RESEARCH ORGANIZATIONS (CROS)
    • OTHER END USER
  5. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREATS OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
    • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • PESTLE ANALYSIS
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
  6. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
  1. COMPANY PROFILES
    • 3M COMPANY
    • ANTARES PHARMA
    • ASTRAZENECA PLC
    • BAYER AG
    • BECTON, DICKINSON & COMPANY (BD)
    • BOEHRINGER INGELHEIM
    • ELI LILY
    • HOFFMANN-LA ROCHE LTD.
    • GLAXOSMITHKLINE LLC
    • JOHNSON AND JOHNSON
    • MERCK & CO. INC.
    • NOVARTIS
    • PFIZER, INC.
    • SANOFI

 

LIST OF TABLES

TABLE 1        ASIA PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

TABLE 2        ASIA PACIFIC DRUG DISCOVERY MARKET BY TECHNOLOGY, 2019-2027 ($ MILLION)

TABLE 3        ASIA PACIFIC HIGH THROUGHPUT SCREENING MARKET, 2019-2027 ($ MILLION)

TABLE 4        ASIA PACIFIC BIOCHIPS MARKET, 2019-2027 ($ MILLION)

TABLE 5        ASIA PACIFIC BIOINFORMATICS MARKET, 2019-2027 ($ MILLION)

TABLE 6        ASIA PACIFIC PHARMACOGENOMICS AND PHARMACOGENETICS MARKET, 2019-2027 ($ MILLION)

TABLE 7        ASIA PACIFIC COMBINATORIAL CHEMISTRY MARKET, 2019-2027 ($ MILLION)

TABLE 8        ASIA PACIFIC NANOTECHNOLOGY MARKET, 2019-2027 ($ MILLION)

TABLE 9        ASIA PACIFIC SPECTROSCOPY MARKET, 2019-2027 ($ MILLION)

TABLE 10      ASIA PACIFIC METABOLOMICS MARKET, 2019-2027 ($ MILLION)

TABLE 11      ASIA PACIFIC OTHER TECHNOLOGIES MARKET, 2019-2027 ($ MILLION)

TABLE 12      ASIA PACIFIC DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION)

TABLE 13      ASIA PACIFIC SMALL MOLECULE DRUG MARKET, 2019-2027 ($ MILLION)

TABLE 14      ASIA PACIFIC BIOLOGIC DRUG MARKET, 2019-2027 ($ MILLION)

TABLE 15      ASIA PACIFIC DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION)

TABLE 16      ASIA PACIFIC DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 17      ASIA PACIFIC CHEMICAL SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 18      ASIA PACIFIC BIOLOGICAL SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 19      ASIA PACIFIC OTHER PHARMACEUTICAL SERVICES MARKET, 2019-2027 ($ MILLION)

TABLE 20      ASIA PACIFIC DRUG DISCOVERY MARKET, BY END USER, 2019-2027 ($ MILLION)

TABLE 21      ASIA PACIFIC RESEARCH INSTITUTES MARKET, 2019-2027 ($ MILLION)

TABLE 22      ASIA PACIFIC PHARMACEUTICAL COMPANIES MARKET, 2019-2027 ($ MILLION)

TABLE 23      ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET, 2019-2027 ($ MILLION)

TABLE 24      ASIA PACIFIC OTHER END USER MARKET, 2019-2027 ($ MILLION)

TABLE 25      ASIA PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)

 

LIST OF FIGURES

FIGURE 1      ASIA PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 2      ASIA PACIFIC DRUG DISCOVERY MARKET SHARE BY TECHNOLOGY 2018 & 2027 (%)

FIGURE 3      ASIA PACIFIC DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION)

FIGURE 4      ASIA PACIFIC DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION)

FIGURE 5      ASIA PACIFIC DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION)

FIGURE 6      ASIA PACIFIC DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION)

FIGURE 7      ASIA PACIFIC DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION)

FIGURE 8      ASIA PACIFIC DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION)

FIGURE 9      ASIA PACIFIC DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION)

FIGURE 10   ASIA PACIFIC DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION)

FIGURE 11   ASIA PACIFIC DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION)

FIGURE 12   ASIA PACIFIC DRUG DISCOVERY MARKET SHARE BY DRUG TYPE 2018 & 2027 (%)

FIGURE 13   ASIA PACIFIC DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION)

FIGURE 14   ASIA PACIFIC DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION)

FIGURE 15   ASIA PACIFIC DRUG DISCOVERY MARKET SHARE BY SERVICE 2018 & 2027 (%)

FIGURE 16   ASIA PACIFIC DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2027 ($ MILLION)

FIGURE 17   ASIA PACIFIC DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION)

FIGURE 18   ASIA PACIFIC DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION)

FIGURE 19   ASIA PACIFIC DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION)

FIGURE 20   ASIA PACIFIC DRUG DISCOVERY MARKET SHARE BY END USER 2018 & 2027 (%)

FIGURE 21   ASIA PACIFIC DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)

FIGURE 22   ASIA PACIFIC DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION)

FIGURE 23   ASIA PACIFIC DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION)

FIGURE 24   ASIA PACIFIC DRUG DISCOVERY MARKET, BY OTHER END USER, 2019-2027 ($ MILLION)

FIGURE 25   PORTER’S FIVE FORCE MODEL

FIGURE 26   CHINA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 27   INDIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 28   JAPAN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 29   SOUTH KOREA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 30   AUSTRALIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

FIGURE 31   REST OF ASIA PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

Segmentation

  1. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
  1. MARKET BY TECHNOLOGY
    • HIGH THROUGHPUT SCREENING
    • BIOCHIPS
    • BIOINFORMATICS
    • PHARMACOGENOMICS AND PHARMACOGENETICS
    • COMBINATORIAL CHEMISTRY
    • NANOTECHNOLOGY
    • SPECTROSCOPY
    • METABOLOMICS
    • OTHER TECHNOLOGIES
  2. MARKET BY DRUG TYPE
    • SMALL MOLECULE DRUG
    • BIOLOGIC DRUG
  3. MARKET BY SERVICE
    • DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
    • CHEMICAL SERVICES
    • BIOLOGICAL SERVICES
    • OTHER PHARMACEUTICAL SERVICES
  4. MARKET BY END USER
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL COMPANIES
    • CONTRACT RESEARCH ORGANIZATIONS (CROS)
    • OTHER END USER

Request Free Sample

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now

Inkwood Research